When determining the fair value of biological assets and there is no market price for that asset in its present condition AASB 141 requires that:
A) the entity uses the present value of expected net cash flows from the asset discounted at a current market-determined pre-tax rate.
B) the entity measure the asset at cost.
C) the entity uses the contract prices for recent sales of similar assets adjusted for the effects of biological transformation.
D) the entity uses sector benchmarks.
Correct Answer:
Verified
Q8: Which of the following is NOT a
Q12: Which of the following is NOT a
Q13: Agricultural produce is defined in AASB 141
Q14: At 30 June 2013 the fair
Q15: AASB 141 requires that biological assets be
Q16: AASB 141 applies to the accounting for
Q18: Increases in fair value over cost in
Q19: AASB 141 requires disclosure of which of
Q22: Which of the following is NOT considered
Q23: Use the following information to answer
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents